Inner Mongolia Furui Medical Science Co., Ltd. (SHE: 300049)

Inner Mongolia Furui Medical Science Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,320	1,147	1,001	891.56	800.96	824.38
Other Revenue	6.9	6.9	7.37	6.93	6.57	7.36
Revenue	1,327	1,154	1,009	898.48	807.53	831.74
Revenue Growth (YoY)	20.96%	14.37%	12.27%	11.26%	-2.91%	-4.07%
Cost of Revenue	335.03	291.39	267.67	239.14	226.65	239.06
Gross Profit	991.56	862.34	741.09	659.34	580.88	592.68
Selling, General & Admin	587.84	527.56	474.49	405.7	361.47	388.55
Research & Development	98.43	82.47	70.82	64.79	65.82	60.75
Other Operating Expenses	11.78	10.43	10.79	12.5	11.39	11.74
Operating Expenses	707.05	617.39	562.68	491.94	440.51	450.22
Operating Income	284.51	244.95	178.41	167.4	140.38	142.45
Interest Expense	-1.06	-0.9	-1.58	-2.33	-3.21	-2.97
Interest & Investment Income	6.73	12.39	9.73	10.54	3.41	0.72
Currency Exchange Gain (Loss)	-2.32	-2.32	7.93	16.48	-12.48	2.88
Other Non Operating Income (Expenses)	3.2	-0.53	-1.28	-0.26	-0.25	-0.69
EBT Excluding Unusual Items	291.05	253.59	193.21	191.83	127.84	142.4
Gain (Loss) on Sale of Investments	-	-	-	-	-1.6	-15.63
Gain (Loss) on Sale of Assets	-0.45	-0.82	-1.86	-3.46	-6.93	0.01
Asset Writedown	-4.71	-4.71	-0	-	-	-0.07
Other Unusual Items	-12.41	-12.66	0.29	0.77	-5.32	-0.07
Pretax Income	273.48	235.4	191.63	189.14	113.99	126.64
Income Tax Expense	58.95	58.29	46.22	41.1	23.72	26.52
Earnings From Continuing Operations	214.53	177.11	145.41	148.04	90.27	100.13
Minority Interest in Earnings	-84.13	-75.55	-47.52	-52.57	-28.36	-56.74
Net Income	130.4	101.56	97.89	95.47	61.91	43.39
Net Income to Common	130.4	101.56	97.89	95.47	61.91	43.39
Net Income Growth	18.23%	3.75%	2.54%	54.22%	42.69%	22.50%
Shares Outstanding (Basic)	265	263	263	260	256	256
Shares Outstanding (Diluted)	265	263	263	260	256	256
Shares Change (YoY)	0.82%	-0.01%	1.30%	1.31%	0.03%	-5.93%
EPS (Basic)	0.49	0.39	0.37	0.37	0.24	0.17
EPS (Diluted)	0.49	0.39	0.37	0.37	0.24	0.17
EPS Growth	17.27%	3.76%	1.22%	52.22%	42.65%	30.23%
Free Cash Flow	30.96	115.66	98.69	142.94	90.41	189.93
Free Cash Flow Per Share	0.12	0.44	0.38	0.55	0.35	0.74
Dividend Per Share	-	-	0.200	-	-	-
Gross Margin	74.75%	74.74%	73.47%	73.38%	71.93%	71.26%
Operating Margin	21.45%	21.23%	17.69%	18.63%	17.38%	17.13%
Profit Margin	9.83%	8.80%	9.70%	10.63%	7.67%	5.22%
Free Cash Flow Margin	2.33%	10.02%	9.78%	15.91%	11.20%	22.84%
EBITDA	358.58	312.12	236.39	221.12	209.72	193.45
EBITDA Margin	27.03%	27.05%	23.43%	24.61%	25.97%	23.26%
D&A For EBITDA	74.07	67.18	57.98	53.71	69.35	50.99
EBIT	284.51	244.95	178.41	167.4	140.38	142.45
EBIT Margin	21.45%	21.23%	17.69%	18.63%	17.38%	17.13%
Effective Tax Rate	21.56%	24.76%	24.12%	21.73%	20.81%	20.94%
Revenue as Reported	1,327	1,154	1,009	898.48	807.53	831.74
Advertising Expenses	-	4.76	9.83	9.3	5.62	6.94

Source: S&P Capital IQ. Standard template. Financial Sources.